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ABSTRACT 
GAS bacterium is a successful human pathogen that causes a variety of diseases of the skin 
and pharynx and results in about 500,000 deaths worldwide. The pathogenesis of GAS 
diseases is highly complex. GAS virulence is regulated by several two-component regulatory 
systems (TCS) constituted by a response regulator (RR) and its cognate histidine kinase (HK). 
HK autophosphorylates on its His residue and transfers the phosphate to the conserved Asp-
residue of RR, which acts as a transcription factor and regulates the expression of specific 
genes. SptR/S (Spy874/875) is an important TCS that regulates the expression of many 
carbohydrate-metabolism and transport (CMT)-related genes. GAS mutants lacking SptR 
display down-regulated CMT-related genes and are avirulent. Previously, our lab discovered 
that similar phenotypic characteristics were also observed in GAS mutants when the gene 
encoding for ser/thr kinase (STK) was deleted. We therefore hypothesize that STK 
phosphorylates SptR and its phosphorylated form regulates the expression of CMT-related 
genes. STK phosphorylates threonine residues. Whether Thr-phosphorylation of SptR plays any 
role in the regulation of gene expression is not known. In in vitro phosphorylation assays, we 
found that the purified SptR serves as a substrate for STK and ser/thr phosphatase (STP)-
mediated reversible phosphorylation. To confirm this finding in vivo and appreciate its 
physiological significance, we immunoprecipitated (ip) SptR from the whole cell lysate derived 
from the wild-type GAS, and previously characterized GAS mutants M1ΔSTK and M1ΔSTP 
using SptR specific antibodies. We confirmed isolation of the 27kDa ip-protein to be SptR by 
anti-SptR antibody and its threonine phosphorylation status by Anti-ThrP antibody by Western 
blot analysis. Our results showed decreased and increased anti-ThrP-specific binding with 
ipSptR from GAS mutants M1ΔSTK and M1ΔSTP, respectively, confirming that SptR indeed 
serves as a substrate for the STK/STP-mediated reversible Thr-phosphorylation. We thus 
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INTRODUCTION 
Group A Streptococcus (GAS, S. pyogenes) is an important gram-positive, chain-forming 
extracellular bacterium that colonizes the human pharynx and skin. It is responsible for causing 
a variety of diseases that range from uncomplicated pharyngitis and skin infections including 
impetigo, erysipelas, and cellulitis to scarlet fever and life-threatening invasive illnesses such as 
pneumonia, bacteremia, necrotizing fasciitis, streptococcal toxic shock syndrome, and 
nonsuppurative sequelae (acute rheumatic fever, rheumatoid arthritis, and glomerulonephritis) 
(Carapetis et al., 2005). Cases of severe GAS disease cause more than 500,000 deaths per 
year worldwide (Cohen-Poradosu and Kasper, 2007). 
 GAS possesses a variety of cell-associated and secreted virulence factors to remain as 
a successful pathogen. Surface-bound and secreted proteins expressed by GAS play important 
functions in bacterial adhesion, invasion, and proliferation. Various toxins including extracellular 
pyrogenic exotoxins A, B, and C, exotoxin F, and streptococcal superantigen SSA elicit the 
large non-specific activation of T cells and cause the production of inflammatory interleukins and 
cytokines (Cunningham, 2000). GAS also secretes proteins, toxins, and enzymes –including 
hydrolases and esterases– that play a role in tissue invasion and the degradation of proteins, 
nucleic acids, polysaccharides, and lipids. The expression of many of these proteins is 
dependent on bacterial growth and is controlled by two-component regulatory systems (TCS) 
composed of an environmental sensor, a sensor histidine kinase (HK), and a response regulator 
(RR) (Stock et al., 2000). GAS possesses 13 such TCS (Ribardo et al., 2004). TCS, thus, play a 
crucial role in regulating the genes responsible for successful colonization and infection by GAS. 
Typically, HKs are signal-transduction transmembrane enzymes that monitor a cell’s 
external environment and respond to extracellular cues, such as those produced by nutrients, 
chemoattractants, osmotic conditions, and quorums (Stock et al., 2000). Canonically, the HK 
autophosphorylates on a conserved histidine residue and transfers the inorganic phosphate 
group to the conserved aspartic-residue of the co-transcribing RR. Structurally, the RR 
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possesses two distinct domains, the N-terminal receiver and C-terminal DNA-binding domain. 
The activity of an RR is dependent on the aspartate phosphorylation on its N-terminal receiver 
domain, which brings substantial conformational changes to its carboxy-terminal DNA-binding 
domain (Stock et al., 2000). The Asp-phosphorylated RRs bind more efficiently to the promoter 
DNA and drive the transcription of the specific downstream genes. RR thus serves as a 
transcription factor.   
Recently, in prokaryotes, an analogous alternative signaling mechanism mediated by 
serine/threonine kinases (STKs) and co-transcribing phosphatases (STPs) has been recognized 
and received importance as the mono-component regulatory system (Pereira et al 2011). STKs 
in bacterial pathogens including GAS have been linked to the regulation of key posttranslational-
based cellular functions such as metabolic and developmental processes, stress response, 
biofilm formation, cell wall biosynthesis, sporulation, drug resistance, and virulence (Pereira et 
al., 2011). Previously, our laboratory has demonstrated that GAS ser/thr kinase (STK, SPy1625) 
and phosphatase-(STP, SPy1626)-mediated Thr phosphorylation and dephosphorylation 
respectively regulate the transcriptional function of the two other important RRs of TCS, CovR 
and WalR in GAS (Agarwal et al., 2012).  
Among the 13 TCS found in GAS, three have been found to regulate GAS virulence: 
CovR/S, WalR/S, and SptR/S CovR/S (control of virulence) regulates capsule and hemolysin 
production as a negative regulator (Churchward, 2007). WalR/S (wall synthesis regulating) 
regulates cell division and cell wall synthesis (Winkler and Hoch, 2008). Lastly, newly 
recognized SptR/S (for saliva persistence, SPy874/875) regulates many carbohydrate-
metabolism and transport (CMT)-related genes (Shelburne et al., 2005). Although our laboratory 
has shown that STK/STP-mediated reversible phosphorylation regulates the functionality of 
CovR and WalR in GAS, it is unknown whether SptR is similarly regulated by STK/STP in GAS. 
GAS lacks the Krebs cycle and hence, it uses glucose as the primary carbon source for 
its growth. In this thesis, I address the topic of GAS’s successful pathogenicity, which causes a 
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variety of systemic invasive diseases in environments where glucose is unavailable. The 
importance of SptR lies in the crucial role that carbohydrate metabolism plays in GAS virulence 
regulation. SptR/S-regulated gene expression enables GAS to survive in glucose-depleted or 
non-glucose environmental niches and to utilize complex carbohydrates (non-glucose) present 
in human body fluids including saliva (hence saliva persistence). GAS mutants lacking SptR are 
avirulent and display down-regulated CMT-related genes (Shelburne et al., 2005). Similarly, 
GAS mutants lacking STK also display down-regulated CMT-related genes, but without any 
change in the expression level of SptR (Kant et al., submitted). This indicates that there is a 
direct physiological and biochemical link between STK function and CMT-related gene 
expression.  
We therefore hypothesize that in the absence of STK, the functionality of SptR is altered. 
If our hypothesis is correct, STK should be able to phosphorylate SptR. STP should 
dephosphorylate SptR-P both in vitro and in vivo. 
 
MATERIALS AND METHODS  
Bacterial Strains and Reagents:  
GAS mutants M1ΔSTK and M1ΔSTP lacking STK and STP, respectively, were made as 
described earlier (Jin and Pancholi, 2006; Agarwal et al., 2011) and obtained from our stock 
collection. Mutants were grown in Todd Hewitt broth supplemented with 0.5% yeast extract and 
spectinomycin (500 µg/ml) or kanamycin (200 µg/ml). These mutants were derived from the 
wild-type M1SF370 strain. Escherichia coli (DH5a or XL-1 and BL21 pLysS) strains were grown 
in Luria-Bertanii medium supplemented with or without ampicillin (100 µg/ml). All other 
chemicals were obtained from Sigma Chemicals, unless otherwise indicated.  
Cloning of the SPy874 gene and production of His-tag recombinant protein:   
The 669 nt open reading frame in the M1SF370 assigned as SPy874 was PCR amplified 
using forward and reverse primers containing Xho1 and BamH1 restriction sites, respectively. 
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Using the pGEM-T vector system and T4 ligase, the PCR product was ligated. The ligation 
mixture was then used to transform E. coli XL-1 strain by the chemical transformation method 
using competent cells and the colonies harboring pGEMT-SptR plasmid were selected on LB 
agar containing ampicillin. pGEM-SptR plasmid was then purified using Qiagen plasmid 
purification kit. As shown in figure 3, the plasmid was double digested with Xho1/BamH1and the 
669 bp fall-out fragment was then gel purified using Qiagen DNA gel purification kit. The purified 
DNA fragment was ligated between the Xho1/BamH1 site of double digested His-tag vector 
pET14b at 16°C overnight. The ligation mixture was then used to transform E. coli (XL-1 strain) 
sptR positive, (as determined by PCR using for forward and reverse primers as described 
above) and ampicillin resistant E. coli colony were selected. This strain was stored at -70°C until 
further use. Plasmid pET14b-sptR was then purified from E. coli Xl-1 strain and subsequently 
used to transform BL21 DE3 (PlysS) strain. 
Purification of Recombinant SptR Protein: 
pET14b-SptR-transformed E. coli was grown overnight in LB broth containing ampicillin 
(100 µg/ml) under constant rotation at 37 °C. On the following day, 100 ml of LB broth was 
inoculated with 1 ml of overnight culture and grown to an optical density 0.3-0.4 (2- 3 hr) as 
described above and was induced with 1mM IPTG and further incubated for 3-4 h. The culture 
was then pelleted and suspended in binding buffer (50 mM Tris/HCl, pH 8.0, 0.15 M saline and 
10 mM imidazole, protease inhibitor, DNAse and RNAse, 5 mM MgCl2). After repeated freezing 
and thawing, the cells were sonicated. The lysate thus obtained was centrifuged (10,000 g) for 
20 min at 4°C. The supernatant and pellet were fractionated. Following this, the pellet was 
suspended in the above buffer containing 8M urea. The solubilized pellet was further 
centrifuged (10,000 g for 20 min at 4°C) and the debris-free supernatant was separated. Both 
native and denatured supernatant were subjected separately for purification as shown in the 
schematic diagram (figure 4). 
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 Briefly, recombinant His-tag protein was purified by Ni-NTA-affinity column 
chromatography using three (50, 100, 250 mM) step-up gradients of imidazole in the Tris-buffer 
described above. Then, 2 ml of lysate was poured onto the column and fall through was 
recovered. The column was washed with 5 column volumes and subsequently eluted with 5 
column volumes of each step up gradient buffer. Eluted fractions were examined for the 
presence of the 27 kDa SptR protein by SDS-PAGE electrophoresis.  
Raising Antisera against SptR: 
Rabbit polyclonal sera against the recombinant Histag-SptR was custom-raised 
(Lampire Biomedicals) employing the express protocol of 50 days of immunization as described 
on their website. Bleed out sera were checked for the high titer antibody against His-tagged 
SptR recombinant protein by western blot analysis, as described below. 
In vitro Reversible Phosphorylation of SptR by SP-STK and SP-STP: 
Phosphorylation assay was carried out using a reaction mixture containing SptR (2 µg), STK 
(0.2 µg), γ32P-ATP (1 µCi) and 5 mM MnCl2 and incubated for 30 min at room temperature. A 
duplicate sample was then treated with SP-STP. The phosphorylation of SptR by SP-STK and 
SP-STP was analyzed by autoradiography. 
In vivo Phosphorylation: 
Determination of in vivo Thr phosphorylation status of SptR in the M1-Wt, M1ΔSTK, 
M1ΔSTP mutant strains was carried out as schematically presented in figure 5. Briefly, the 
whole lysate from the overnight cultures of the above strain was obtained by treating the 
washed bacterial pellet with recombinant phage lysin (amidase) to digest the cell wall in 50 mM 
Tris/HCl buffer, pH 8.0, DNAse, RNAse and protease inhibitor. Subsequently, a debris free 
supernatant was obtained after high-speed centrifugation (16,000 g for 20 min at 4 °C). This 
was then used as the starting material for immunoprecipitation. Anti-SptR was used to 
immunoprecipitate SptR present in the above-mentioned bacterial lysates. Immunoprecipitated 
SptR-Ab complex was fractionated by incubation with protein-A Sepharose beads that 
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specifically bound to the Fc-portion of anti-SptR antibodies. Using low centrifugation force, the 
proteinA-sepharose linked SptR-Anti-SptR ab complex was removed and thoroughly washed 
with washing buffer containing non-ionic detergent to remove non-specifically bound proteins 
(other than IgG molecules). The purified immunoprecipitated complex was then suspended in 
denaturing sample buffer for SDS-PAGE and western blot analysis. 
SDS-PAGE Western Blot Analysis: 
The proteins in the given samples were first suspended in 4x denaturing sample buffer 
(containing b-mercaptoethanol) and boiled for 2 min. The proteins in the samples were then 
resolved by 15% SDS-PAGE electrophoresis. For in vivo phosphorylation analysis, three 
samples (20 µl each of wt, M1ΔSTK and M1ΔSTP mutant lysates) were run in triplicate to 
perform Coomassie staining and western blot analysis using anti –SptR and anti-threonine-P 
antibodies. The amount of immunoprecipitated SptR was determined by Coomassie stained gel. 
The integrity of the immunoprecipitated SptR was determined by the reactivity to anti-SptR 
antibody on Western immunoblot analysis. The status of Thr phosphorylation of 
immunoprecipitated SptR from the M1 wild-type and isogenic M1ΔSTK and M1ΔSTP GAS 
mutants was measured on Western blots using anti-Thr-P monoclonal antibody, which 
specifically reacts with Thr-P phosphorylated protein.   
 
RESULTS 
 Based on our stated hypothesis, we targeted SptR protein as the possible substrate for 
group A streptococcal serine/threonine kinase and phosphatase. Since we already have STK 
and STP-specific mutants derived from M1SF370, we investigated the presence of SptR 
homolog in M1SF370 genome for this investigation. We then cloned and expressed the 
corresponding gene and purified recombinant protein. Subsequently, we examined whether the 
recombinant SptR serves as a substrate for STK and STP under both in vitro and in vivo 
conditions. 
	   9	  
SPy0874 (SptR) is a response regulator of a novel Two-component regulatory system in 
the M1SF370 Genome: 
By BLAST and other bioinformatics tools and NCBI web resources, we found that the 
sptR gene is encoded by a 669 bp open reading frame spy874, located between nucleotides  
number 721,374 and 722,042. This gene is conserved in other completely sequenced M1 
serotypes also (figure 6). 
Location of the sptR gene (SPy_0874) in M1SF370 genome and its protein sequence: 
 A 669 bp sptR-specific DNA fragment was PCR-amplified using forward and reverse 
primers containing Xho1 and BamH1 restriction sites respectively (see materials and methods). 
The sptR-specific PCR product was cloned in pGEM-T vector at the T-over hang site. After 
restriction digestion the PCR fragment was cloned in pET14b between XhoI and BamH1 sites to 
allow in-frame expression of the sptR gene with upstream 6xHis-encoding tagged. The ligation 
product was then used to transform XL-1 E. coli strain and ampicillin-resistant colonies were 
selected to determine the presence of pET14b-SptR plasmid. The latter was purified from the 
positive clones and was used to transform BL-21 pLysS E. coli strain. Colony PCR was 
performed on several colonies. The sptR(+ve) E. coli clone was grown in LB-ampicillin medium 
until O.D. 0.35 and then induced with 1 mM IPTG for 4 h.  Bacterial pellet was obtained from 
this induced clone. The pellet was lysed in 20 mM TRIS/HCl pH 8.0 containing 10 mM imidazole 
binding buffer. 
 The SptR was purified using Ni2+-NTA affinity column as described in the materials and 
method section. The proteins present in the fall-through, washed and eluted fractions were then 
resolved by SDS-PAGE and examined by Coomassie stain. As shown in figure 7, the SptR was 
eluted from the column when buffer containing 200 mM imidazole was employed. A substantial 
portion of this protein was also found in the pellet fraction. Hence, using a strategy of purifying 
denatured protein, a pellet suspended in 8M urea was used as the starting material. The 
purification pattern remained essentially the same as described above. However, for further 
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analysis, we dialyzed the denatured protein, employing multiple dialysis using a buffer system 
with sequentially reducing urea content i.e. TRIS buffer with 4 M followed by 2 M, 1 M and 0 M 
urea. This allowed us to refold the protein. The purified protein was then used for in vitro 
phosphorylation assays.  
In vitro Phosphorylation of SptR 
 SP-STK is a transmembrane protein (Jin and Pancholi, 2006). Earlier attempts from our 
lab have shown that the yield of the whole protein is low and degrades very rapidly.  However, 
the kinase domain (hereafter referred as STKK) is a soluble enzymatically active fragment and 
can easily be purified (Jin and Pancholi, 2006)  
In vitro phosphorylation assay was carried out using a reaction mixture containing SptR 
(2 µg), STKK (0.2 µg), γ 32P-ATP (1 µCi) and 5 mM MnCl2 and incubated for 30 min at room 
temperature as described in material and methods. As shown in figure 8, STKK (36 kDa 
fragment) autophosphorylated in the presence of γ 32P-ATP and also phosphorylated SptR (27 
kDa). However, when this reaction mixture was treated with recombinant STP (27 kDa Protein), 
there was substantial decrease in phosphorylation due the dephosphorylation reaction mediated 
by STP. We also observed that with extended incubation for 1hr, or by increasing the amount of 
STP with the same 30 min of incubation, both STKK and SptR were completely 
dephosphorylated (data not shown). Notably, SptR in the absence of STK but in the presence of 
only ATP was not phosphorylated, indicating that the reversible phosphorylation of SptR was 
mediated by STKK and STP. 
In vivo Phosphorylation 
To determine whether the observed in vitro STK-mediated phosphorylation of SptR 
indeed occurs in vivo and thus iphysiologically relevant, we isolated SptR from the wild-type with 
intact STP and STK expression and mutant GAS strains that lack either STK (M1ΔSTK) or STP 
(M1ΔSTP) and determined their phosphorylation status. SptR was isolated from the lysates of 
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these strains by employing the immunoprecipitation method as described in materials and 
methods, using polyclonal anti-SptR antibody.   
As shown in figure 9, the Coomassie stain confirmed the presence of the 
immunoprecipitated SptR from the wild-type, and isogenic M1ΔSTK and M1ΔSTP mutants and 
Western blot analysis with Anti-SptR antibody confirmed the specificity and integrity. The 
comparison of the densitometric analysis of Coomassie-stained and corresponding anti-SptR 
reacting protein bands revealed equal amount of SptR proteins in all the GAS strains. The 
reactivity of anti-ThrP antibody revealed a significant decrease in the reactivity of SptR 
recovered from the M1ΔSTK vs. M1ΔSTP, indicating that in the absence of STK, threonine 
phosphorylation of SptR was adversely affected. This correlates with our earlier finding showing 
poor growth of M1ΔSTK in complex carbohydrates (Kant S. et al 2013 unpublished data). 
 
DISCUSSION 
Knowing that GAS uses glucose as a primary source of energy and growth, in the 
present investigation, we have addressed the important topic of GAS’s survival and proliferation 
to remain as a successful pathogen in a host environment where glucose concentration is either 
highly depleted or absent. SptR/S is an important TCS that regulates the expression of many 
carbohydrate-metabolism and transport (CMT)-related genes including those regulating 
maltose-transport (MalT), maltose-metabolism (MalR), and GAS virulence. SptR is up-regulated 
in GAS when grown in saliva, of which maltose is a major constituent (Shelburne et al., 2005). 
GAS mutants lacking SptR are non-virulent and unable to grow in saliva. SptR function is likely 
regulated by its cognate SptK (SPy 875). Previously, our lab observed similar phenotypic 
characteristics revealing down-regulation of MalR and MalT in GAS mutants when the ser/thr 
kinase (STK) encoding gene was deleted (Kant S. et al 2013 unpublished data). Thus far, it is 
not known that SptR can be phosphorylated by other non-canonical kinases. In the present 
investigation, we establish that SptR, in addition to the canonical pathway as reported before 
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(Shelburne et al., 2005), is also phosphorylated by SP-STK. SP-STP (co-transcribing ser/thr 
phosphatase), on the other hand, dephosphorylates Thr-phosphorylation (-PThr) both in vitro and 
in vivo. It is so far not known where SptR binds and how it regulates carbohydrate metabolism.  
For future studies, we propose that SptR-PThr may bind to the upstream promoters of 
malR (PmalR) and malT (PmalT) more efficiently and subsequently regulate the transcription of 
malR and malT.  Our ongoing studies will address this hypothesis and may reveal the 
mechanism of STK/STP mediated fine-tuning of response regulator function by post-
translational modification of Thr residues.  The identification of specific Thr residues in the SptR 
by mass spectrometry may broaden our understanding about the STK/STP mediated regulation 
of carbohydrate metabolism and how GAS remains a metabolically fit and successful pathogen.    
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FIGURE LEGENDS: 
 
Figure-1. Group A Streptococcus (GAS, S. pyogenes) morphology and health consequences of 
GAS colonization in the human body. (A) The gram-positive, chain-forming characteristics of 
Group A Streptococcus (GAS, S. pyogenes) are visible under a microscope after gram staining 
(Chamberlain, 2013). (B) Throat infections, forming a white patch in the pharyngeal area, as 
well as tonsillitis, indicated by enlarged tonsils, are the result of GAS colonization of the human 
pharynx (Kaneshiro et al., 2012). (C) Necrotizing fasciitis (infected leg) is also caused by GAS 
and is known as flesh-eating disease. It is a rare infection that penetrates into the deeper layers 
of the skin (Hu, 2002). 
 
Figure-2. Classical prokaryotic two-component systems regulation. The schematic diagram 
above displays the basis of our hypothesis as to how our recently identified SptR (SPy0874) 
and SptS (SPy0875) is likely to function based on the classical prokaryotic TCS functioning. 
Upon autophosphorylation of HK on a conserved histidine residue, the phosphate group is 
transferred to the conserved Asp-residue found on the RR. Dimerization followed by the 
initiation of transcription occurs once the DNA binding domain of the SptR binds to the DNA 
binding site.  
 
Figure-3. Preparation of pET14B-SptR plasmid and transformation in BL21 E. coli strain. 
Schematic diagram showing a stepwise strategy for the expression of sptR gene by was cloning 
the PCR product in pET14B vector and expression in BL21 E. coli strain under IPTG induction.  
 
Figure-4. Purification of recombinant SptR protein. Schematic diagram depicting stepwise 
strategies (native and denaturing) for the purification of IPTG-induced recombinant protein by 
affinity chromatography employing Ni-NTA solid-phase column.	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Figure-5. In vivo Thr phosphorylation status of SptR in the M1-Wt wild-type and M1ΔSTK, 
M1ΔSTP mutant GAS strains. Schematic diagram depicting a stepwise strategy to isolate 
differentially phosphorylated in vivo expressed SptR in different GAS strains using anti-SptR 
antibody and Protein A-Sepharose-4B. 
 
Figure-6. Location of the sptR gene (SPy_0874) in M1SF370 genome and its encoded protein 
sequence. 
 
Figure-7. Purification of recombinant His-tag SptR. SDS-PAGE shows the presence of 27kDa 
protein in the eluted fractions on Ni-NTA column. Identification of SptR by anti-SptR antibody. 
FT- Fall-though sample. Wash- fraction collected with buffer containing 50mM imidazole. 
Elution- fractions collected with buffer containing 200mM imidazole. The last lane shows the 
reactivity of SptR with anti-SptR antibody. 
 
Figure-8. In vitro phosphorylation of SptR. Autophosphorylation of SptR was carried out by SP-
STK using 32γP –ATP. SptR-ThrP was dephosphorylated by SP-STP.  
 
Figure-9. In vivo differential phosphorylation status of SptR in the wild-type M1SAF370 and 
ΔSTK and ΔSTP GAS mutants. Immunopreciptated SptR from different GAS strains as revealed 
by Coomasie stain (A) and its reactivity with anti-SptR antibody (B) and anti-Thr-P monoclonal 
antibody (C) as revealed by chemiluminiscence-based visualization assay. Quantitative analysis 
of the antibody-reactive bands as determined from three independent experiments and 
analyzed statistically by Student’s T-test. P value less than 0.05 was treated as significant 
difference.  
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Figure 1. Group A Streptococcus (GAS, S. pyogenes) morphology and health consequences of 
GAS colonization in the human body. 
 A                                  B                                                     C
	   	  
	   18	  






































Transformed  and maintained 
in XL-1 E. coli strain
Transformed  and SptR expressed
in  BL21 E. coli strain
pET14B-SptR plasmid 
preparation

























































































	   21	  






















































	   23	  






























	   24	  

































	   25	  



















































Figure 9. In vivo differential phosphorylation status of SptR in different GAS strains. 
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